Viral evolution toward change in receptor usage: Adaptation of a major group human rhinovirus to grow in ICAM-1-negative cells

Journal of Virology

Volumn 75, Issue 19, 2001, Pages 9312-9319

  Reischl, A ^a   Reithmayer, M ^a   Winsauer, G ^a   Moser, R ^a   Gosler I ^a   Blaas, D ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

CAPSID PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; MONOCLONAL ANTIBODY; VERY LOW DENSITY LIPOPROTEIN RECEPTOR;

ADAPTATION; ARTICLE; CELL TRANSPORT; HELA CELL; HUMAN; HUMAN CELL; HUMAN RHINOVIRUS; MOLECULAR CLONING; MOLECULAR EVOLUTION; NONHUMAN; PRIORITY JOURNAL; RNA SEQUENCE; VIROGENESIS; VIRUS REPLICATION;

EVOLUTION, MOLECULAR; GENOME, VIRAL; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; RECEPTORS, VIRUS; RHINOVIRUS; VIRUS REPLICATION;

EID: 0034853339     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.75.19.9312-9319.2001     Document Type: Article

References (50)

1. In vitro studies of the antirhinovirus activity of soluble intercellular adhesion molecule-1 Antimicrob
2. Cell recognition by foot-and-mouth disease virus that lacks the RGD integrin-binding motif: Flexibility in aphthovirus receptor usage
3. PCR amplification of up to 35-kb DNA with high fidelity and high yield from lambda bacteriophage templates
4. Human rhinovirus HRV14 uncoats from early endosomes in the presence of bafilomycin
5. 3 inhibit binding and infection of foot-and-mouth disease virus to cultured cells
6. Comparison of surface properties of picornaviruses: Strategies for hiding the receptor site from immune surveillance
7. Isolation of a monoclonal antibody that blocks attachment of the major group of human rhinoviruses
8. Evidence for the direct involvement of the rhinovirus canyon in receptor binding
9. Rhinoviruses
10. Rhinoviral receptor discrimination: Mutational changes in the canyon regions of human rhinovirus types 2 and 14 indicate a different site of interaction
11. Evolutionary relationships within the human rhinovirus genus: Comparison of serotypes 89, 2, and 14
12. The cell attachment site on foot-and-mouth disease virus includes the amino acid sequence RGD (arginine-glycine-aspartic acid)
13. Receptors of the low density lipoprotein (LDL) receptor family in humans. Multiple functions of the large family members via interaction with complex ligands
14. Mechanisms of receptor-mediated rhinovirus neutralization defined by two soluble forms of ICAM-1
15. The cellular receptor to human rhinovirus 2 binds around the 5-fold axis and not in the canyon: A structural view
16. Members of the low density lipoprotein receptor family mediate cell entry of a minor-group common cold virus
17. Formation of rhinovirus-soluble ICAM-1 complexes and conformational changes in the virion
18. Efficient infection of cells in culture by type O foot-and-mouth disease virus requires binding to cell surface heparan sulfate
19. Crystal structure of human rhinovirus serotype-1A (Hrv1A)
20. Structural studies of two rhinovirus serotypes complexed with fragments of their cellular receptor
21. Detection of major group rhinoviruses by soluble intercellular adhesion molecule-1 (sICAM-1)
22. Amplification and cloning of complete enterovirus genomes by long distance PCR
23. Evidence for the role of the P2 protein of human rhinovirus in its host range change
24. Effect of reduced endocytosis induced by hypotonic shock and potassium depletion on the infection of Hep 2 cells by picornaviruses
25. A soluble form of intercellular adhesion molecule-1 inhibits rhinovirus infection
26. Soluble LDL minireceptors-minimal structure requirements for recognition of minor group human rhinovirus
27. Very-low-density lipoprotein receptor fragment shed from HeLa cells inhibits human rhinovirus infection
28. Recombinant soluble low density lipoprotein receptor fragment inhibits minor group rhinovirus infection in vitro
29. 3 as its receptor
30. The structure of human rhinovirus 16
31. Structure of a human rhinovirus complexed with its receptor molecule
32. Uncoating of human rhinovirus serotype 2 from late endosomes
33. Virus-mediated release of endosomal content in vitro: Different behavior of adenovirus and rhinovirus serotype 2
34. RGD-dependent entry of coxsackievirus A9 into host cells and its bypass after cleavage of VP1 protein by intestinal proteases
35. Efficient RGD-independent entry process of coxsackievirus A9
36. Expression and folding of human very-low-density lipoprotein receptor fragments: Neutralization capacity toward human rhinovirus HRV2
37. The canyon hypothesis. Hiding the host cell receptor attachment site on a viral surface from immune surveillance
38. Structure of a human common cold virus and functional relationship to other picornaviruses
39. Cell recognition and entry by rhino- and enteroviruses
40. Major- and minor-receptor group human rhinoviruses penetrate from endosomes by different mechanisms
41. Coxsackievirus A21 binds to decay-accelerating factor but requires intercellular adhesion molecule 1 for cell entry
42. A decay accelerating factor binding strain of coxsackievirus B3 requires the coxsackievirus adenovirus receptor protein to mediate lytic infection of rhabdomyosarcoma cells
43. Use of monoclonal antibodies to identify four neutralization immunogens on a common cold picornavirus human rhinovirus 14
44. A cell adhesion molecule. ICAM-1, is the major surface receptor for rhinoviruses
45. LDL receptor-related protein: A multiligand receptor for lipoprotein and proteinase catabolism
46. Translation and replication properties of the human rhinovirus genome in vivo and in vitro
47. Isolation of a receptor protein involved in attachment of human rhinoviruses
48. High affinity interactions of coxsackievirus A9 with integrin alpha v beta 3 (CD51/61) require the CYDMKTTC sequence of beta 3, but do not require the RGD sequence of the CAV-9 VP1 protein
49. Involvement of beta2-microglobulin and integrin alphavbeta3 molecules in the coxsackievirus A9 infectious cycle
50. The major and minor group receptor families contain all but one human rhinovirus sero-type